Security key
61023L108
- Security type / class
- Equity / COM
- Total 13F shares
- 192,440
- Total 13F value
- $164,536
- Share change
- -39,175
- SEC-reported price per share
- $0.86
- Number of holders
- 8
- Value change
- -$72,950
- Number of buys
- 4
- Number of sells
- 6
Report period
Q2 2023
Institutions
8
Top holders
8
MNPR full security history
Ownership snapshot
Full 13F holder table
Monopar Therapeutics SEC filings
Monopar Therapeutics company facts
Monopar Therapeutics 13D/G history
Broader feeds
Ownership snapshot
Top reported holders of MNPR - MONOPAR THERAPEUTICS INC - COM (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
VANGUARD GROUP INC
Disclosed value leader
VANGUARD GROUP INC
Comparable rows
0/13
Latest evidence
31 Mar 2023
13F
3/4/5
Highest disclosed value: $138,977
13 rows are not safely comparable across share classes.
Showing 1-6 of 13 holder rows.
Quick read
VANGUARD GROUP INC has the largest disclosed position value at $139K.
0 of 13 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens VANGUARD GROUP INC's linked filing trail.
Disclosed position value
Top 5
VANGUARD GROUP INC
$139K
Andrew Paul Mazar
$94.4K
GEODE CAPITAL MANAGEMENT, LLC
$59.5K
NORTHERN TRUST CORP
$51.5K
KESTRA PRIVATE WEALTH SERVICES, LLC
$32.6K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 13 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| VANGUARD GROUP INC |
13F
Company
|
—
denominator unverified
|
$138,977
99,976 shares
|
— | 31 Mar 2023 |
| Andrew Paul Mazar |
3/4/5
Chief Scientific Officer, Director
|
—
mixed-class rows
|
$94,434
277,584 shares
mixed-class rows
|
— | 31 Mar 2022 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
—
denominator unverified
|
$59,486
41,892 shares
|
— | 31 Mar 2023 |
| NORTHERN TRUST CORP |
13F
Company
|
—
denominator unverified
|
$51,505
37,051 shares
|
— | 31 Mar 2023 |
| KESTRA PRIVATE WEALTH SERVICES, LLC |
13F
Company
|
—
denominator unverified
|
$32,605
23,455 shares
|
— | 31 Mar 2023 |
| Rappaport Reiches Capital Management, LLC |
13F
Company
|
—
denominator unverified
|
$14,867
10,695 shares
|
— | 31 Mar 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2023
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
8
Shares
192,440
Rows available
8
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2023 vs Q1 2023 Across Filers
Q1 2023 holders
11
Q2 2023 holders
8
Holder diff
-3
| Investor | Q1 2023 Shares | Q2 2023 Shares | Share Diff | Share Chg % | Q1 2023 value | Q2 2023 value | Value change | Value Chg % |
|---|